A detailed history of Daiwa Securities Group Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 490 shares of MRVI stock, worth $2,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
490
Previous 490 -0.0%
Holding current value
$2,548
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$26.05 - $37.48 $2,761 - $3,972
106 Added 27.6%
490 $14,000
Q4 2021

Feb 03, 2022

BUY
$35.0 - $45.94 $13,440 - $17,640
384 New
384 $16,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $684M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.